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Transforming growth factor beta (TGF-β) proteins play important roles in morphogenesis of many craniofacial tissues; however, detailed
biological mechanisms of TGF-β action, particularly in vivo, are still poorly understood. Here, we deleted the TGF-β type I receptor gene Alk5
specifically in the embryonic ectodermal and neural crest cell lineages. Failure in signaling via this receptor, either in the epithelium or in the
mesenchyme, caused severe craniofacial defects including cleft palate. Moreover, the facial phenotypes of neural crest-specific Alk5 mutants
included devastating facial cleft and appeared significantly more severe than the defects seen in corresponding mutants lacking the TGF-β type II
receptor (TGFβRII), a prototypical binding partner of ALK5. Our data indicate that ALK5 plays unique, non-redundant cell-autonomous roles
during facial development. Remarkable divergence between Tgfbr2 and Alk5 phenotypes, together with our biochemical in vitro data, imply that
(1) ALK5 mediates signaling of a diverse set of ligands not limited to the three isoforms of TGF-β, and (2) ALK5 acts also in conjunction with
type II receptors other than TGFβRII.
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Facial malformations including cleft lip and cleft palate are
among the most common human birth defects, which often arise
from a poorly understood failure in cell–cell and/or matrix–cell
signaling. In this context, the key cell types are epithelial cells
derived from the ectoderm and ectomesenchymal cells largely
derived from the neural crest (Francis-West et al., 1998). Both
these cell types express multiple components of the transform-
ing growth factor beta (TGF-β) signaling pathway, which has
been shown to play a critical role in many aspects of craniofacial
development, including palatogenesis (Dudas and Kaartinen,
2005). TGF-βs typically signal via heterotetrameric receptor⁎ Corresponding author.
E-mail address: vkaartinen@chla.usc.edu (V. Kaartinen).
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.05.030complexes composed of two type II (TGFβRII) and two type I
(ALK5) receptors, which phosphorylate intracellular mediators
known as receptor-regulated rSmads (Smad2, Smad3). Phos-
phorylated rSmads, in turn, complex with Smad4 and
translocate into the nucleus to modulate transcription of target
genes (Massague and Chen, 2000; Derynck and Feng, 1997).
Although multiple alternative (non-canonical) downstream
pathways have also been identified (Dudas and Kaartinen,
2005), their exact connection to TGF-β receptors is currently
unknown.
The palate, i.e., the upper wall of the oral cavity, is formed
from two embryonic palatal shelves, which fuse in the midline
(Ferguson, 1988). The fusion process requires a tight mutual
adhesion of the two apposing shelves and a subsequent
degradation of the epithelial seam, resulting in mesenchymal
confluence (Dudas and Kaartinen, 2005). Mice deficient in
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(Sanford et al., 1997; Kaartinen et al., 1995; Proetzel et al.,
1995). Whereas Tgf-β2 is expressed in the palatal mesenchyme,
Tgf-β3 expression is strictly limited to the pre-fusion palatal
midline epithelium (Dudas et al., 2004a; Saika et al., 2001;
Sanford et al., 1997; Dickson et al., 1993). Based on studies
using misexpression and chemical inhibition, it has been
suggested that the TGF-β/ALK5/Smad2 pathway has an
important function in disintegration of the midline seam (Cui
et al., 2005; Dudas et al., 2004a). Three major mechanisms for
the MES (midline epithelial seam) disintegration have been
proposed in recent literature: apoptosis, cell migration, and
epithelial-to-mesenchymal transdifferentiation (Martinez-
Alvarez et al., 2000). However, the exact epithelium-specific
role of TGF-β signaling via ALK5 in palatal fusion in vivo is
still to be defined.
The mesenchyme underlying the palatal epithelium is
formed from the craniofacial neural crest (CNC), a pluripotent
cell population originating from the dorsal ridges of the neural
tube (Ito et al., 2003). Many mouse mutants lacking genes that
control proliferation of palatal mesenchymal cells display
defects in palatal fusion, thus confirming that controlled growth
and patterning of the palatal mesenchyme is a prerequisite for
successful palatal fusion in vivo (Dudas and Kaartinen, 2005;
Martinez-Alvarez et al., 2004; Rice et al., 2004; Brewer et al.,
2004; Dudas et al., 2004b; Darling et al., 2003; Zhang et al.,
2002; Beverdam et al., 2001; Lavrin et al., 2001; Qu et al.,
1999; Satokata and Maas, 1994). Several signaling processes
have been shown to control neural crest cells (NCCs) in a cell-
autonomous fashion (Sasaki et al., 2005; Brewer et al., 2004;
Jeong et al., 2004; Dudas et al., 2004b; Ito et al., 2003; Tallquist
and Soriano, 2003; Brault et al., 2001). Among these pathways,
TGF-β/BMP superfamily signaling is of particular interest
because many TGF-β-related ligands have been shown to play
indispensable roles in facial development (Dudas et al., 2004b;
Ito et al., 2003; Taya et al., 1999; Sanford et al., 1997; Kaartinen
et al., 1995; Proetzel et al., 1995).
Studies on the roles of TGF-β/BMP receptors during facial
development in vivo have been hampered by the fact that
embryos lacking these genes die before the face is formed.
Recently, tissue-specific gene knockout technologies utilizing
Cre/loxP recombination have become powerful tools, which can
be used to circumvent this problem. Here, we deleted the TGF-
β type I receptor ALK5 specifically in the ectodermal epithelial
and neural crest lineages by crossing mice carrying the
conditional Alk5flox allele (Larsson et al., 2001) with K14-Cre
mice (Andl et al., 2004), or with Wnt1-Cre mice (Danielian et
al., 1998). In both cases, the resulting mutant mice display
impaired palatal fusion. Moreover, neural crest-specific Alk5
mutants demonstrate severe nasal clefting with associated
mandibular hypoplasia and several other craniofacial defects.
These phenotypes differ remarkably from those seen in
corresponding Tgfbr2 mutants (Ito et al., 2003), suggesting
that during facial morphogenesis, ALK5 may also become
activated by an additional mechanism that does not require a
function of its typical binding partner, the TGF-β type II
receptor.Materials and methods
Mice and genotyping
Mice carrying Alk5flox and Alk5KO alleles were PCR genotyped as described
(Larsson et al., 2001). Wnt1-Cre mice were a generous gift from A. McMahon
and Rosa26R (R26R) Cre-reporter mice were purchased from the Jackson Labs
(for detailed PCR-genotyping, see http://www.jax.org); K14-Cre mice were
obtained from S. Millar (Andl et al., 2004). Tgf-β3−/−mice were generated in our
laboratory (Kaartinen et al., 1995). All mice were maintained on mixed genetic
backgrounds. All studies were carried out at the Animal Care Facility of the
Saban Research Institute in accordance with national and institutional guidelines.
Histology and stainings
Tissues were fixed with 4% formaldehyde for 12h, and paraffin sections
were stained with hematoxylin–eosin. Embryos were stained for β-galactosi-
dase activity as described (Hogan et al., 1994). Briefly, the specimens were fixed
in 4% formaldehyde for 30min, washed in the detergent wash, and developed in
the X-Gal solution. Skeletal staining with alcian blue and alizarin red dyes, and
tissue clearing were performed as published (McLeod, 1980).
Electron microscopy
E14 heads with exposed pre-fusion palatal shelves were fixed in phosphate-
buffered 4% formaldehyde with 0.2% glutaraldehyde for 24h and processed at
DEI/USC/Norris Cancer Center Cell and Tissue Imaging Core. Pictures were
recorded using the scanning electron microscope with computerized digital
capture (Hitachi S-570). Cells were counted on both palatal shelves of each
genotype, in areas of 20×40μm (approximately 20 cells), the longer side being
parallel with the AP axis of palatal shelves.
Expression studies
Screening for expression changes was performed using expression arrays
(GEArray® Q Series Mouse TGF-β/BMP Array, SuperArray Cat. # MM-023)
according to manufacturer's instructions and accompanying software analysis
tool and quantitative RT-PCR assays (Roche LightCycler®with Roche TaqMan®
probes and primers designed online, http://www.roche-applied-science.com).
Whole-mount and section in situ hybridization experiments were used to
visualize the relevant expression patterns and carried out as described (Moorman
et al., 2001; Hogan et al., 1994). We used probes specific forMsx1 (Furuta et al.,
1997), Msx2 (Ishii et al., 2003), Tgfbr2 (Ito et al., 2003), Alk5 (Dudas et al.,
2004a), Bmpr2 (nucleotides 1070–1566; accession number NM_007561),
Acvr2A (nucleotides 1040–1277; accession number NM_007396) and Acvr2B
(nucleotides 627–998; accession number NM_007397), Fgf8 (Tanaka et al.,
1992), Tgif (nucleotides 343–755, accession number NM_009372), and Gdf11
(nucleotides 247–703, ID number ENSMUST00000026408, and Nakashima
et al., 1999).
Apoptosis and cell proliferation
Apoptotic cells were detected in paraffin sections as a green fluorescence using
DeadEnd Fluorometric TUNEL system (Promega). Cell proliferation was
immunodetected using the phospho-histone H3 antibody (Cell Signaling) and
Cy3-conjugated secondary antibody (Jackson ImmunoResearch Laboratories).
Positively stained cells were countedmanually in defined areas of tissues. Statistical
analysis of cell counts in serial sections and comparison of mutant specimens with
controls was performed using non-parametric Wilcoxon rank sum test.
Palatal organ culture and bead implantation
Mice were mated during the dark period of the controlled light cycle;
presence of vaginal plugs was designated as day 0, hour 0. Females were
euthanized by CO2, and E14 embryos were collected in Hanks' balanced salt
solution on ice. Palatal shelves were microdissected, placed on Millipore filter
discs, and cultured in BGJb medium (Gibco) supplemented with vitamin C
Fig. 1. Epithelial deletion of Alk5 causes impaired fusion of palatal shelves and posterior palatal cleft. Alk5/K14-Cre pups (G-J) are born with a defect in the posterior
part of the soft palate (arrow in panel G). In contrast, Tgf-β3 null newborns have a complete bilateral palatal cleft (M–P; arrows in panel M), whereas control newborns
(A–D) have palates fully fused. The upper row shows stereoscopic images of formalin-fixed newborn heads after removal of the mandible (magnification 5×), the next
three rows show histological sections through three different antero-posterior positions (a, b, c), as indicated in panel M (hematoxylin–eosin, magnification 20×). Alk5/
K14-Cre palatal shelves dissected on E14 fail to fuse in organ culture (L), whereas wild-type shelves (F) fuse normally (hematoxylin-eosin, magnification 40×). The
fourth row (E, K, Q) demonstrates decreased proportion of cells with filopodia (asterisks) by E14 at the edges of pre-fusion palatal shelves in the Alk5/K14-Cremutants
(K) and Tgf-β3 null embryos (Q), in comparison with controls (E) (Scanning electron microscopy, magnification 5 000×). (R) Comparison of proportion of cells with
filopodia in pre-fusion palatal shelves. Cells were counted in three areas (anterior, medium, posterior; 20×40μm) of the two palatal shelves for each genotype, and
averaged within each group. f—the site of fusion of palatal shelves; ns—nasal septum; *—cells with filopodia.
300 M. Dudas et al. / Developmental Biology 296 (2006) 298–314
301M. Dudas et al. / Developmental Biology 296 (2006) 298–314(Kaartinen et al., 1997). Agarose beads (Affi-Gel Blue, Bio-Rad) were washed
in PBS and incubated for 30min at 37°C in 0.1% BSA in PBS, with or without
5ng/ml TGF-β3 (Sigma). Beads were washed in a culture medium and placed
between the edges of dissected palatal shelves during the arrangement of organ
culture experiments, as described above. Tissues were harvested after 12h of
culture at 37°C and 6% CO2 in humidified air, before the midline seam
disintegrated.
Expression vectors, transfections, and Western blot analyses
Expression vectors for human Smad2 and rat Alk5 cDNAwere obtained from
Rik Derynck. A segment of rat Alk5 cDNA encoding the intracellular portion of
ALK5 (nucleotides 541–1543; accession number L26110) was PCR-amplified
and subcloned in-frame into the SpeI site of the pC4-RHE plasmid. A fragment of
cDNA encoding the entire kinase domain of Tgfbr2 (nucleotides 901–2027;
accession number NM_009371) and Acvr2B (nucleotides 602–1651; accession
number NM_007397) was reverse-transcribed and PCR-amplified from the
mouse embryonal RNA (E10) and subcloned in-frame into the pC4M-F2E
plasmid. pC4-RHE and pC4M-F2E plasmids were from Argent Heterodimeriza-
tion kit (Ariad Pharmaceuticals, http://www.ariad.com/regulationkits. All
constructs were sequenced to exclude mutations introduced by PCR and to
verify in-frame ligation. DR26 cells were cultured in D-MEM/F12 medium
(Invitrogen) and transfected on 24-well plates. For each transfection, 200ng of
Smad2 vector, 400ng of type II receptor vector, and 400ng of Alk5 vector were
mixed with 2.0μl of Lipofectamine™ 2000 in a total volume of 100μl of Opti-
MEM (Invitrogen). The cells were incubated with the DNA/Lipofectamine
mixture for 24h at 37°C, 5% CO2. Subsequently, cells were washed and
incubated with 0nM, 50nM, and 500nM concentrations of the heterodimerizer
(AP21967 from Ariad Pharmaceuticals). After 40min, cells were lysed in 2×
Laemmli sample buffer and analyzed using Western blotting. Anti-phospho-
Smad2 (Upstate Biotech.), anti-Smad2 (Santa Cruz Biotech.), anti-HA (USC
Core facility), and anti-Flag (Sigma) antibodies were used.Fig. 2. TGF-β-induced apoptosis in the midline epithelial seam is required for palatal f
K14-Cre (C) palatal midline regions using TUNEL assay (green fluorescent signal) in
controls (A), whereas positively staining cells cannot be seen in Tgf-β3 and Alk5/K
disappearing midline seam. (D–F) Implantation of TGF-β3 beads (E) into the palatal
epithelial cells up to a level seen in control wild-type explants treated with BSA (boResults
Deletion of Alk5 in the epithelium impairs palatal fusion
To dissect the function of ALK5 in the palatal epithelium
during palatogenesis, we crossed mice carrying the floxed Alk5
allele (Alk5flox/flox) with K14-Cre transgenic mice (Andl et al.,
2004), which were also heterozygous for the Alk5 knockout allele
(i.e.,Alk5KO/WT/K14-Cre+/−). Twenty-five percent of the resulting
mutant embryos were compound heterozygotes for the Alk5flox
and Alk5KO alleles, and carried K14-Cre, a transgene encoding
the Cre recombinase under the control of the K14 promoter
(herein termed Alk5/K14-Cre). K14-Cre is specifically expressed
in ectodermal cells, including the palatal epithelium, as early as at
E10 (data not shown), and has been shown to efficiently mediate
the recombination of floxed alleles (Andl et al., 2004).
Despite widespread expression of Alk5 in many ectodermal
locations, epithelial deletion of Alk5 did not result in any
obvious macroscopic pathological features in E14 embryos or in
newborns (data not shown). However, Alk5/K14-Cre mutant
newborn mice died soon after birth, lacking milk in the
stomach. Stereoscopic examination consistently revealed 100%
penetrant cleft in the posterior part of the soft palate, affecting
approximately 20% of the palatal length (Figs. 1G–J).
Subsequent detailed histological analyses of serial sections
(frontal orientation) revealed a persistent midline epithelial
seam and fusion defects also in the remaining anterior portion ofusion. Comparison of apoptotic cell death in control (A), Tgf-β3−/− (B) and Alk5/
embryonic heads fixed on E14.5. Intense clusters of apoptotic cells can be seen in
14-Cre mutants. Arrow in panel A points to TUNEL-positive nuclei inside the
midline region of E14 Tgf-β3−/− explants leads to increased apoptosis of adjacent
vine serum albumin) beads (F). DAPI counterstain, magnification 40×.
Fig. 3. Fate mapping of midline epithelial cells in Alk5/K14-Cre mutants.
Transverse palatal sections of E17 embryos expressing K14-Cre in the Rosa26
reporter background were stained for β-galactosidase activity (blue), which
permanently marks epithelial cells and their descendants (eosin counterstain,
magnification 20×). (A) Control palates have cells derived from the epithelium
exclusively on the oral and nasal side of the palate, whereas the fully confluent
mesenchyme (pink) along the entire anterior–posterior axis is devoid of
positively staining cells. (B–F) Alk5/K14-Cre mutants show either no adhesion
(cleft) or adhesion with a lack of fusion detected as persistent midline epithelial
seam in the anterior palate (blue staining and arrows). Moreover, the nasal
septum has failed to fuse with palatal shelves (B). The posterior part of the palate
shows a stretched epithelial bridge (E), followed by palatal cleft in the most
posterior region of the soft palate (F).
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area of the palate seemed to be well adhered at the time of
inspection (Fig. 1G); the anterior cleft (Fig. 1H) was not visible
and may have appeared during tissue fixation and dehydration,
suggesting that the midline seam in Alk5/K14-Cre mutant is
formed, but remains persistently weak throughout the embry-
onic development until birth. In addition, the anterior portions
of palatal shelves consistently failed to fuse with the nasal
septum (Fig. 1H).
Next we used serial sectioning to compare histological
details of palatal fusion between mutants and controls at E14
(pre-fusion), at E14.5 (during adherence and fusion), and at E15
and E17 (post-fusion). Before and during palatal fusion, both
mutant and control samples looked identical. At E14.5, palatal
shelves of both genotypes formed the midline seam spanning
about 90% of the total palate length, with small unadhered areas
corresponding to the anterior and posterior regions. During later
stages (E15 and E17), while control specimens demonstrated
complete fusion, mutant palatal shelves were adherent but
displayed a persistent midline seam, except in the areas of the
posterior and anterior ends of the palate. The posterior regions
demonstrated a cleft similar to the cleft in newborns shown in
Fig. 1—albeit less extensive in size (less than 5% of the seam
length in mutants on E15, and about 15% on E17). No
differences in mesenchymal cell proliferation or apoptosis were
found in Alk5/K14-Cre mutants, not even in the posterior or
anterior ends of palatal shelves that failed to establish contact
with the apposing shelf. Progressive increase in the relative size
of the posterior cleft accounts for the final cleft reaching 20% of
the palate length in Alk5/K14-Cre newborns. Moreover, in
organ culture, Alk5/K14-Cremutant shelves dissected from E14
embryos and placed within close contact displayed a persistent
midline seam, confirming that the primary cause of the fusion
defect is epithelial malfunction (Fig. 1L). These findings
indicate that ALK5 plays an indispensable role in the
disappearance of the palatal epithelial seam during palatal
fusion, which in turn leads to clefting, particularly in the
anterior and posterior aspects of the secondary palate.
Palatal edges of Alk5/K14-Cre mutants show a reduced
number of cells with filopodia
It has been reported that MEE cells deficient in TGF-β3 fail
to form filopodia on their apical surface (Taya et al., 1999), with
implications to failed palatal fusion. Therefore, we have
compared the MEE ultrastructure between controls, Tgf-β3
knockouts, and Alk5/K14-Cre mutants during the stage when
approximately 5% of the MEEs are in contact. A vast majority
(about 85%) of all MEE cells in controls displayed filopodia,
whereas in both Tgf-β3−/− and Alk5/K14-Cre samples, the
number of filopodia-containing cells was markedly reduced
(16.6 and 15%, respectively; Figs. 1E, K, Q, and R). MEE
surfaces closely adjacent to the regions of adherence showed no
differences in comparison with the remote (both anterior and
posterior) parts of the medial edges. These results demonstrate
that TGF-β3/ALK5 signaling plays a specific role in the
morphological maturation of palatal midline epithelial cells.
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The exact contribution of cell death, migration, and epithelial-
to-mesenchymal transformation to the removal of the MES from
fusing palatal shelves has been discussed for decades (Dudas and
Kaartinen, 2005; Cuervo and Covarrubias, 2004; Martinez-
Alvarez et al., 2000; Shuler, 1995). To analyze, whether ALK5
signaling couldmediate apoptosis in theMEE,we first compared
the number of TUNEL-positive cells between controls, Tgf-β3
knockouts, and Alk5/K14-Cre mutants (Fig. 2). Controls
demonstrated a large number of apoptotic cells, particularly in
the nasal and oral epithelial triangles, whereas apposing Tgf-β3
knockout palatal shelves did not show any positively staining
cells. Although palatal shelves in Alk5/K14-Cre mutants were
adherent, they still failed to display apoptotic cells. Subsequent-
ly, we implanted beads soaked with recombinant TGF-β3 (1mg/
ml BSA; 5ng/ml TGF-β3) between the MEEs of Tgf-β3
knockout palatal explants. After 24-hour organ culture, control
beads (BSA only) did not induce detectable apoptosis, whereas
the explants incubated with TGF-β3 beads displayed a large
number of apoptotic cells in the epithelial seam (Fig. 2E).
To follow the fate of palatal epithelial, we crossed Alk5flox/flox
mice with R26R reporter mice, and subsequently the double
homozygote Alk5flox/flox, R26R+/+ females were crossed with
Alk5KO/WT/K14-Cremales (Jiang et al., 2000; Soriano, 1999). In
resulting embryos, all cells expressing the active recombinase
Cre and their descendants stained positively for β-galactosi-
dase. At E17 (i.e., >2days after the palate has fused), palatal
midlines in controls contained no positively staining mesen-
chymal cells (Fig. 3A), consistent with a report by others
(Vaziri et al., 2005). In contrast, the mutant palates had eitherFig. 4. External facial phenotype of Alk5/Wnt1-Cre mutants. Lateral view of a newbo
embryos are noticeably pale in comparison with controls. (C) Detailed view of the
undersized palatal shelves are marked with P. Coronal sections through the palatal reg
and eosin, ×4). S—nasal septum; P—palatal shelves; T—tongue.failed to adhere or demonstrated a persistent midline seam,
with all epithelial regions sharply demarcated from the
surrounding mesenchyme (Figs. 3B–F). No blue cells were
invading nor joining the mesenchyme in this transitional
region. The transitional region between the adhered and the
cleft (posterior) region of the mutant palates displayed an
elongated, thin epithelial bridge between the two palatal
shelves (Fig. 3E).
Taken together, these findings suggest that epithelial-to-
mesenchymal transdifferentiation (EMT) may not be a major or
a definitive TGF-β-driven mechanism to remove epithelial cells
from the midline seam. Our experiments suggest that TGF-β
signaling contributes to induction of programmed cell death in
the palatal MES. Furthermore, the markedly stretched mor-
phology of the epithelial bridge in the posterior palate of Alk5/
K14-Cremutants suggests that a midline rupture, i.e., secondary
cleft, may occur as an additional clefting mechanism.
ALK5 signaling in neural crest cells is required for normal
craniofacial development
To analyze the role of TGF-β signaling via ALK5 in the
palatal mesenchyme, we crossed the Alk5flox/flox mice with
Alk5KO/WT mice carrying Wnt1-Cre knock-in (Danielian et al.,
1998). In resulting Alk5/Wnt1-Cre embryos, Cre-mediated
conversion of the Alk5flox allele to Alk5KO allele occurs only
in cells that express Wnt1-Cre, i.e., in neural crest (NC) cells,
and in the neural plate. This allows deletion of genes also in
the palatal mesenchyme, which is composed largely of NC-
derived cells. The Alk5/Wnt1-Cre embryos were born alive but
were severely disfigured and died soon after birth. The mostrn control (A) and a mutant (B) showing the malformed face and head. Mutant
oral cavity of the newborn mutant. Arrow points to a cleft snout and upper lip;
ion of control (D) and Alk5/Wnt1-Cre mutant embryos (E) at E18 (hematoxylin
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plastic cranium, split snout, small mandible, cleft palate, and
small tongue (Figs. 4A–C). Histological analyses verified the
presence of a wide cleft between rudimentary palatal shelves
(Fig. 4E). The region of the cranial vault was soft, and several
newborns suffered from skin damage and external bleeding in
that area. Because no such defect was seen if the fetuses were
dissected from the uterus at E19, the forehead and parietal
region were most likely injured during parturition. Addition-
ally, no signs of exencephaly or neural closure defects were
detected.Missing and dysplastic craniofacial skeletal structures in
Alk5/Wnt1-Cre mutants
To characterize the skeletal phenotype of Alk5/Wnt1-Cre
embryos, we utilized the alizarin red and alcian blue staining,
which stains calcified bone red and cartilage blue (Fig. 5).
Calvaria phenotype was practically identical to Tgfbr2/Wnt1-
Cremutants (Ito et al., 2003), i.e., large portions of frontal bones
were missing, and parietal bones were so severely developmen-
tally retarded that they displayed only the most posterior border
(Figs. 5A–D). In contrast, the more posterior structures, such as
305M. Dudas et al. / Developmental Biology 296 (2006) 298–314interparietal and supraoccipital bones, appeared to be well
developed. Unlike the calvaria region, the face of the Alk5/Wnt1-
Cre mice demonstrated a much more severe pathological
phenotype when compared to the corresponding Tgfbr2mutants
(Figs. 4 and 5C–H). Almost all derivatives of the first pharyngeal
arch were strongly affected. The nasal cartilage displayed a wide
cleft, and both the squamosal zygomatic and maxillary
zygomatic processes, as well as jugal bones, were absent.
Moreover, the squamosal bones were missing, including the
retrotympanic process. The premaxillary bones were hypoplas-
tic, and both the palatal and maxillary bones were rudimentary
and far apart, consistent with the presence of cleft palate.
Meckel's cartilage was abnormally curved in the posterior part,
and the tympanic ring was underdeveloped. The mandible was
very small, and lacked identifiable coronoid, condylar, and
angular processes. Moreover, the anterior cranial base, which is
also derived from neural crest cells (Couly et al., 1993), lacked
the presphenoid bone (Figs. 5E–F). Similarly, the middle ear
ossicles were also abnormal; the manubrium of malleus was
hypoplastic and the incus was missing. The stapes, derived from
the second arch, was completely absent, and multiple additional
structures derived from pharyngeal arches II–VI (Figs. 5I–J)
showed severe and unique abnormalities, not found in
corresponding Tgfbr2/Wnt1-Cre mutants (Ito et al., 2003).
Fate mapping of neural crest cells in Alk5/Wnt1-Cre mutants
The fate of Alk5-deficient neural crest cells was followed
during craniofacial development using the Rosa26 Cre reporter
(R26R) β-galactosidase assay at E8.5, E11, and E15. Detailed
analysis revealed that the staining pattern was indistinguishable
between mutants and controls (Fig. 6). Intriguingly, this
analysis also demonstrated that whereas the neural crest cells
populate the pharyngeal region at E8.5–E11, the maxillary
process of the first pharyngeal arch, as well as both nasal
processes, fails to form properly and appear much smaller in
mutants than in controls (Figs. 6E–H). In concordance with
these findings, the mutant embryos display severe facial cleftingFig. 5. Bone and cartilage defects resulting from deletion of Alk5 in neural crest cells.
side, mutants on the right. Stereoscopic magnification ×5; magnification ×7 used for
defect in calvaria, which is almost completely missing in Alk5/Wnt1-Cre mutants. O
around the cranial base (long arrowheads). Shortened mandible (arrow) and multiple
prominent skeletal features of Alk5/Wnt1-Cre embryos, together with almost comp
Superior view shows a lack of all three components of the zygomatic arch (arrowhead
missing calvaria as mentioned above (long arrowheads). (E–F) Inferior view after rem
palate (circled) due to rudimentary palatine, maxillary, and premaxillary palatal com
bones; asterisk marks missing presphenoid ossification. (G–H) Lateral view of the m
show remarkable differences when compared to control littermates in the persisten
secondary cartilages, and impaired middle ear bones (missing incus and stapes, incom
rudiments of the hyoid bone and thyroid cartilage appear as multiple small elem
cricoarytenoid complex is positioned abnormally low, at the level of the upper tho
arrowhead points to a midline cartilage of unknown origin. alsph—alisphenoid bone
bone; ang.sc—secondary cartilage of the angular process; ary—arytenoid cartilage; b
secondary cartilage of the condylar process; cric—cricoid cartilage; f—frontal bone
lesser horn of the hyoid bone; i—incus; ip—intraparietal bone; f.car—foramen car
process of Meckel's cartilage; mx—maxilla; mx.alv—alveolar process of maxilla; m
—nasal cartilages; no—used for missing structures; occ.b—basis of the occipital bon
bone; pmx—premaxilla; pmx.palat—palatal process of premaxilla; s—stapes; sq—sq
process; thyr—thyroid cartilage; tymp.r—tympanic ring; zyg—zygomatic (jugal) boat E15, although the facial processes are heavily populated with
cells derived from the neural crest (Figs. 6K–L).
Signaling via ALK5 in the neural crest is necessary for
mesenchymal cell survival in the first pharyngeal arch
Analysis of Tgfbr2/Wnt1-Cre mutant embryos has shown
that TGF-β signaling is required for cell proliferation in the
palatal mesenchyme (Ito et al., 2003). We therefore hypothe-
sized that the observed phenotypes in Alk5/Wnt1-Cre mutants
could be caused by defective cell proliferation in the maxillary
and mandibular processes of the first pharyngeal arch. Mutant
and control embryos did not display significant differences in
cell proliferation at E8.5, E9, E10, and E11 (Fig. 7). Sub-
sequently, we considered the possibility that signaling via ALK5
would be necessary for cell survival. The rate of programmed
cell death was determined using the TUNEL assay in the paraffin
sections immediately adjacent to those used for the proliferation
assays. Up until E9, identical size, shape, and apoptotic patterns
were detected in pharyngeal arches of controls and mutants. The
earliest detectable difference between themwas observed at E10,
when there was a slight change in the location (lateralization) of
a typical patch of apoptotic cells apparent within the maxillary
arch (Figs. 7A–D), whereas no differences were seen in the
mandibular arch (Figs. 7E–H). By E11, Alk5/Wnt1-Cremutants
had a distinct increase in the number of apoptotic cells in the first
pharyngeal arch (Figs. 7I–T) and forebrain (not shown). In
summary, these results demonstrate that ALK5 signaling is
critically involved in the regulation of cell death within the
mesenchyme of the first pharyngeal arch.
Changes in proliferation and apoptosis in the palatal
mesenchyme
To dissect the mechanism of palatal clefting in Alk5/Wnt1-
Cremutants on the cellular level, we analyzed growth, elevation,
and fusion of palatal shelves between E12 and birth. Although
mutant palatal shelves appeared symmetrically on the maxillaryBone (red) and cartilage (blue) staining in E18 embryos; controls are on the left
panels G and H, ×15 for panels I and J. (A–B) Lateral views demonstrate a large
nly small portions of the parietal and frontal bones remain and form a thin ring
anomalies in the region of the absent temporomandibular joint (circled) are other
letely missing laryngeal cartilages and hyoid bone (short arrowhead). (C–D)
s), cleft in the region of nasal cartilages underlying the cleft snout (arrows), and
oval of the mandible with middle ear ossicles reveals a large defect in the bony
ponents. Arrowheads point to locations of missing squamosal and alisphenoid
andibular complexes with Meckel's cartilage and middle ear ossicles. Mutants
ce and curvature of Meckel's cartilage (asterisk), defects in formation of the
plete tympanic ring). (I–J) Semilateral view of the laryngeal region. In mutants,
ents scattered in an anatomically correct location (double arrowheads). The
racic aperture, resulting in a gap in the laryngeal skeleton (arrow). The long
; alsph.l.obtur—lamina obturans; alsph.pter—pterygoid process of alisphenoid
sph—basisphenoid bone; cochl—cochlear part of the temporal bone; cond.sc—
; hyo—hyoid bone; hyo.grhorn—greater horn of the hyoid bone; hyo.lhorn—
oticum; f.ov—foramen ovale; gon—gonium; m—malleus; Meck.ant—anterior
x.palat—palatal process of maxilla; mx.zyg—zygomatic process of maxilla; nas
e; p—parietal bone; palat—palatal bone; palat.palat—palatal process of palatal
uamous bone; sq.rtp—retrotympanic process of the squamal bone; styl—styloid
ne.
Fig. 6. Normal neural crest cell migration but pronounced hypomorphism of mandibular, maxillary, and nasal processes in Alk5/Wnt1-Cre mutants. Embryos carrying
the Rosa26 Cre reporter were stained for β-galactosidase activity. (A–D) Migration of neural crest cells (blue) in controls at E8.5 (A–B) is indistinguishable from
mutants (C–D). (E–F) Control at E11. (G–H) Alk5/Wnt1-Cre mutant at E11. White mx in G marks an undersized maxillary process, arrow in panel H points to an
enlarged gap between nasal pits, corresponding to the future clefting region (compare with panel L). Long arrowhead—forebrain vesicles protruding frontally
(aggravated in panel K); short arrowhead—hypoplastic maxillary process. (I–J) Control littermate at E15. (K–L) Alk5/Wnt1-Cre mutant at E15. Long arrowhead
points to frontally protruding forebrain region, double arrowhead points to a small mandible, and arrow indicates the facial cleft. II—2nd pharyngeal arch; fnm—
frontonasal mass; mnd—mandibular process of the 1st pharyngeal arch; mx—maxillary process of the 1st pharyngeal arch.
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distinct hypoplasia. Between E14 and birth, these rudimentary
shelves were located bilaterally in the horizontal orientation
(Fig. 4E). Consistent with the findings of increased apoptosis in
the mesenchyme of pharyngeal arches at E11, the palatal
mesenchyme of Alk5/Wnt1-Cre mutants was affected with a
dramatic increase in apoptosis (Fig. 8D). In addition, we
detected more than 6-fold increase in the average number of
proliferating mesenchymal cells per shelf cross-section (Figs.
8A–B, E). These results show that signaling via ALK5 is
required for cell survival not only in the early facial mesenchyme
at E10 and E11, but also in the palatal mesenchyme at E14.
Changes in downstream gene expression in Alk5/Wnt1-Cre
mutants
To identify signaling pathways that could link impaired
signaling via ALK5 to the severe facial phenotype seen in
Alk5/Wnt1-Cre mutants, we performed an extensive screen
for changes in expression of potential target genes. We
employed TGF-β/BMP signaling expression arrays, as well as
individual qRT-PCR-based assays for rationally chosen genesinvolved in facial midline development. Significant changes in
expression of Msx1, Fgf8, and Tgif were identified (not
shown) and visualized by in situ hybridization (Fig. 9).
Msx genes are well-documented effectors of TGF-β/BMP
(Bei and Maas, 1998; Suzuki et al., 1997). At E10, Msx1 is
normally expressed in the ectomesenchyme of both the maxillary
and distal mandibular processes of the first pharyngeal arch
(Tucker et al., 1998). In contrast,Msx1 expression was markedly
reduced in the maxillary primordia of Alk5/Wnt1-Cre mutants,
whereas the mandibular expression appeared unaffected (Fig.
9B). At E11,Msx1 continued to display attenuated expression in
the maxillary and frontonasal processes (Fig. 9D), whereas the
closely related Msx2 gene did not demonstrate noticeable
differences between controls and mutants at any stage.
Fgf8, another gene important for facial midline development,
displayed a normal characteristic expression pattern in both
controls and mutants at E10. A notable difference in the shape
of the maxillary processes between mutants and controls on E11
did not allow more direct comparison of Fgf8 expression, but
Fgf8 was clearly more intensely expressed in the mutant
anterior maxillary ectoderm at this stage (Fig. 9J), the location
where physiological Fgf8 expression does not occur.
Fig. 7. Increased apoptosis in pharyngeal arches of Alk5/Wnt1-Cremutants. Frontal sections show a pronounced increase in number of TUNEL-positive apoptotic cells
(green signal) in the maxillary (mx) and mandibular (mnd) processes of Alk5/Wnt1-Cremutants on E11, but not on E10, when compared to controls. Cell proliferation
(anti-phospho-histone H3 immunostaining, red signal) is comparable between mutants and controls (blue counterstaining with DAPI; magnification 20×).
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strongly expressed in controls at E11 in the maxillary and
mandibular processes of the first pharyngeal arch, as well as in
the frontonasal processes. In corresponding Alk5/Wnt1-Cre
mutants, expression of Tgif was noticeably reduced in
hypoplastic maxillary and frontonasal primordia, and also in
normally shaped temporoparietal and neck regions (Fig. 9L).
Endogenous co-expression of Alk5 with Gdf11 and type II
receptors in the facial primordia
As outlined above, the facial phenotypes of Alk5/Wnt1-Cre
mutants were more severe than those of the correspondingTgfbr2/Wnt1-Cre mutants (Ito et al., 2003). This raises the
possibility that also other type II receptors, in conjunction with
related TGF-β superfamily ligands, could activate ALK5 in the
MEE and neural crest cells. Indeed, ligands such as GDFs 8, 9,
and 11 have been shown to signal via ALK5 and activin type II
receptors (Mazerbourg et al., 2004; Rebbapragada et al., 2003;
Oh et al., 2002). Whereas GDF8 controls the growth of skeletal
muscles (Hamrick et al., 2002; McPherron and Lee, 1997,
2002), and GDF9 is predominantly expressed in oocytes
(Hanrahan et al., 2004; Carabatsos et al., 1998; Laitinen et al.,
1998; McPherron and Lee, 1993), GDF11 is a likely candidate
to function also in craniofacial morphogenesis. In addition to
being expressed in the tail bud, as previously reported
Fig. 8. Increased apoptosis and proliferation rate in the palatal mesenchyme of
Alk5/Wnt1-Cre mutants and comparison with Alk5/K14-Cre mutants and Tgf-β3
knockouts. (A–B) Proliferating cells labeled with anti-phospho-histone H3
antibody (red fluorescent signal) at E14. (C–D) Apoptotic cells labeled using a
TUNEL assay at E14 (green fluorescent signal). Magnification 20×, DAPI
counterstain. (E) Histogram demonstrating statistically significant increase in
the absolute number of proliferating cells in the mesenchyme of Alk5/Wnt1-Cre
mutants in comparison with wild-type controls, Alk5/K14-Cre mutants, and Tgf-
β3 knockouts (Wilcoxon rank score test, P<0.05; error bars=standard
deviations; N=number of samples; sec= total number of sections analyzed).
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maxillary and mandibular primordia of the first pharyngeal
arch, in lateral and medial nasal processes, in the second
pharyngeal arch, and palatal shelves (Figs. 10A–C). We have
also compared the expression patterns of Alk5 and type II
receptors at the onset of craniofacial morphogenesis (Figs.
10D–H). Alk5 was uniformly expressed in the developing head,
including the pharyngeal arches, with the most intense signal
arising from the forebrain. Type II receptors displayed typicalwidespread expression with certain small areas staining stronger
than the rest of the tissues, demonstrating a significant overlap
with Alk5 expression.
ALK5 can form functional signaling complexes with
unconventional type II receptors in vitro
To further explore the possibility that ALK5 could be
activated by several different type II receptor kinases in vivo,
we made use of the rapamycin-based regulated heterodimeriza-
tion system (Stockwell and Schreiber, 1998; Rivera et al.,
1996). This methodology is based on a finding that the non-
immunosuppressive rapamycin analogue AP21967 induces
heterodimerization between an FKBP12 protein domain and a
mutated version of a large PI3K homolog FRAP called FRB*,
without interfering with the activity of endogenous FRAP
(Pollock et al., 2000).
We constructed a mammalian expression vector encoding the
FRB*-ALK5 cytoplasmic domain fusion protein (FRB*-
ALK5cyt). In addition, we generated vectors containing a
myristoylation sequence, two FKBP domains, and either the
TGFβRII kinase domain (Myr-FKBP-TGFβRII-kin) or ACV-
RIIB kinase domain (Myr-FKBP-ACVRIIB-kin) (Figs. 11A–
B). We expected that these constructs could associate
conditionally upon addition of the heterodimerizer AP21967,
which would subsequently lead to the phosphorylation of a
downstream signal transducer, Smad2, as shown in the
schematic model (Fig. 11B). The constructs were transfected
into Tgfbr2-deficient DR26 cells together with the Smad2
expression vector. After 24h, the cellular extracts were prepared
and analyzed for Smad2 phosphorylation.
In the absence of the dimerizer, Smad2 phosphorylation
was undetectable. Addition of the dimerizer to cells co-
transfected with Myr-FKBP-TGFβRII-kin and FRB-ALK5cyt
induced strong Smad2 phosphorylation, consistent with the
earlier findings of Stockwell and Schreiber. They showed that
this system can be used to investigate the mechanisms of
Smad activation resulting from formation of a complex
between cytoplasmic domains of TGFβRI and TGFβRII
(Stockwell and Schreiber, 1998). Moreover, Myr-FKBP-
ACVRIIB-kin and FRB-ALK5cyt fusion proteins, in the
presence of the heterodimerizer, could also stimulate Smad2
phosphorylation, albeit more than 10-fold less efficiently than
TGFβRII and ALK5 fusion proteins under identical condi-
tions (Fig. 11C).
To conclude, these experiments provide direct biochemical
evidence that ALK5 activation can be induced not only the
kinase activity of TGFβRII, but also by the other type II
receptor kinases such as ACVRIIB, provided that they are
properly associated with each other.
Discussion
TGF-β3/ALK5 signaling and palatal fusion
The role of TGF-β signaling in palatogenesis is well
established; Tgf-β3 expression is both spatially and temporally
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1990; Akhurst et al., 1990; Pelton et al., 1990a,b), and mice
deficient in TGF-β3 demonstrate either a complete bilateral
clefting of the secondary palate (50% of offspring), or posterior
clefting and superficial anterior adherence (Kaartinen et al.,
1995; Proetzel et al., 1995). TGF-β3, as a prototypical TGF-β
ligand, signals via TGFβRII and ALK5, and therefore it was
expected that mice lacking one of these receptors in the MEE
would display a phenotype similar to that of Tgf-β3−/− mice. In
contrast, Alk5/K14-Cre consistently demonstrate posterior
clefting and superficial adherence of the middle and anterior
palate, but never a complete palatal cleft. These differences
could be at least partly attributed to residual expression of Alk5
in the palatal epithelium as a result of incomplete K14-Cre-
induced recombination in the Alk5flox locus. Alternatively,
although no apparent changes in mesenchymal proliferation
have been found in palatal shelves of these mutants, it is
possible that epithelially expressed TGF-β3 enhances reshaping
of the adjacent mesenchyme in the tips of Alk5/K14-Cre palatal
shelves, thus locally improving the shelf midline contact-which
cannot occur in mice completely lacking TGF-β3.
In agreement with the most recent observations (Vaziri et al.,
2005), we show that epithelial–mesenchymal transdifferentia-
tion is not a major TGF-β3-driven mechanism of palatal fusion.
Furthermore, we demonstrate that addition of TGF-β3 beads
into the Tgf-β3−/− midline seam induces apoptosis, providing
additional support for the critical role of programmed cell death
as a primary mechanism of the MES breakdown (Martinez-
Alvarez et al., 2000). As can be seen in Fig. 2, the increase in
apoptosis is not only limited to the close proximity of the soaked
beads, but also occurs in more remote parts of the MES. This
may reflect the fact that the beads could not be firmly
immobilized between the two slippery shelves and traveled
either up or down before reaching their final position (thus
releasing TGF-β3 in multiple locations), or this may have
occurred through protein diffusion.
Anterior–posterior differences in palates of Alk5/K14-Cre
mutants
As noted in Tgf-β3−/− mice (Dudas et al., 2004a; Kaartinen
et al., 1995), Alk5/K14-Cre mutants also show a difference in
fusion of the anterior and posterior parts of the palate, a findingFig. 9. Attenuated expression of Msx1 and changes in expression patterns of
Fgf8 and Tgif in Alk5/Wnt1-Cre mutants. Endogenous gene expression was
visualized by in situ hybridization with biotinylated riboprobes (blue signal,
magnification 5× for E10 and 4× for E11 samples). WhereasMsx2 did not show
any change, Msx1 shows a remarkable decrease in expression in the maxillary
process and frontonasal mass in mutants at E10 (B, arrowheads) and in the upper
nasal pit region at E11 (D, arrowhead). Fgf8 expression in Alk5/Wnt1-Cre
mutants spreads more anteriorly along the lower edge of the maxillary process at
E11 (J, arrowhead), when compared with the control (I). Tgif expression shows
a slight increase in the mandibular process and the 2nd pharyngeal arch in
mutants at E11, whereas its expression in mutants of the same age is attenuated
or absent in the upper portion of the maxillary process of the 1st pharyngeal arch,
frontonasal process, temporoparietal region, and the nuchal area (K–L,
arrowheads) The nasal pits and most of the calvaria show a comparable staining
pattern and intensity in both mutants and controls.
Fig. 10. Endogenous co-expression of Alk5, type-II receptors, and Gdf11 in the facial primordia demonstrated by in situ hybridization. (A–C) Expression of Gdf11 in
the tail and craniofacial primordia. Long arrowhead points to a strong signal in the mandibular arch at E10.5. (D–H)Whole-mount in situ hybridization with riboprobes
for Alk5 (D), Acvr2A (E), Acvr2B (F), Bmpr2 (G), and Tgfbr2 (H). Arrowheads point to a positive signal in the nasal, maxillary and mandibular processes, second
pharyngeal arch, and forebrain. ov—otic vesicle.
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developmental biology (Hilliard et al., 2005). A lack of palatal
fusion in organ culture together with observations of establish-
ing the palatal midline contact suggests that the posterior cleft in
Alk5/K14-Cre mutants cannot be attributed to anterior–
posterior differences in the fusion capability of the MEE.
Normally, the very anterior and posterior parts of the secondary
palate come in contact last and the shape of medial edges of
palatal shelves is not straight but slightly rounded in the anterior
and posterior aspects. As the shelves meet, the midline epithelial
seam gradually disappears by programmed cell death, starting at
the site where the contact was first established. This leads to a
tighter contact between the apposing shelves, assisting other
parts of the palate on the edges of the contact area to get closer
to each other. Therefore, it is not surprising that anterior and
posterior parts of the midline seam may be the first to break
when appropriate epithelial fusion has not occurred, as seen in
Alk5/K14-Cre mutants, and shelves become pulled apart by
lateral growth of the head. Progressive elongation of the
posterior cleft up to 20% of the palate length may result partly
from the growth of the soft palate in length, and partly from
post-adhesion seam rupture.
Filopodia and adherence of palatal shelves
The intercalation of cell membrane protrusions has been
proposed as an important part of the machinery driving the
fusion of epithelial edges in multiple organs during embryonic
development across a wide range of animal species (Martin and
Parkhurst, 2004). Furthermore, it has been suggested that a total
failure of this process causes cleft palate in Tgf-β3 null mice(Taya et al., 1999). Our present data show that both Tgf-β3 null
and Alk5/K14-Cre mutants suffer from a dramatic decrease in
the proportion of MEE cells carrying filopodia. However, the
morphological appearance of the rare cells with filopodia does
not differ from those found abundantly in controls. Keeping in
mind that a significant part of the palatal edges is tightly adhered
in both mutants (Taya et al., 1999; Kaartinen et al., 1995), and
that we did not find any anterior–posterior differences in the
filopodia occurrence, we suggest that filopodia are not an
absolute prerequisite for palatal adherence. The membrane
protrusions in the MEE may play a role in navigation of
apposing shelves towards each other in vivo, and/or may simply
represent a phenotype of terminally differentiated MEE cells
(Takigawa and Shiota, 2004).
Unique spectrum of craniofacial phenotypes in mice lacking
ALK5 in neural crest cells
Several different signaling pathways have been suggested to
function cell-autonomously in NC cells to regulate essential
morphogenetic events during craniofacial development (Brewer
et al., 2004; Dudas et al., 2004b; Ito et al., 2003; Tallquist and
Soriano, 2003; Brault et al., 2001). As we report here,
inactivation of the TGF-β type I receptor gene Alk5 in the
neural crest severely impairs craniofacial development with
100% penetrance. Deletion of Alk5 in the neural crest affected
also cardiovascular development, similarly as in the case of
Alk2/Wnt1-Cre mutants (Kaartinen et al., 2004). Detailed
investigation has revealed that craniofacial and cardiovascular
phenotypes are not dependent on each other. Although the
present study is focused on our findings within the craniofacial
Fig. 11. Activation of ALK5 by two different type II receptors in vitro.
Regulated heterodimerization was used as a model system to test whether ALK5
may also be activated by ACVRIIB in addition to canonical TGFβRII. (A)
Expression constructs for type II receptors contained N-terminal myristoylation
signal (Myr), two copies of FK506 binding domains (FKBP), and regions
coding for kinase domains of ACVRIIB (construct IIA in panel A) and
TGFβRII (construct IIT in panel A), respectively. The ALK5 cytoplasmic
domain was fused to FKBP-rapamycin binding domain (FRB*, see Materials
and methods; construct I in panel A). (B) Heterodimerizing agent (AP21967,
Ariad Pharmaceuticals; brown in the scheme) can be used to induce regulated
heterodimerization of chimeric type I and type II receptor fusion proteins
expressed in cell culture. (C) Western blot analysis shows that the kinase domain
of ACVRIIB was able to activate the ALK5 fusion protein in Tgfbr2-deficient
DR26 cells co-transfected with the Smad2 expression vector, albeit less
efficiently than the corresponding TGFβRII domain, as demonstrated by
phosphorylation of the effector protein Smad2. Left panel-exposure 5min; right
panel—exposure 20min.
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elsewhere.
It is noteworthy that the observed spectrum of facial
malformations in Alk5/Wnt1-Cre mutants is truly unique
among neural crest cell phenotypes. Particularly, the nasal
cleft is rarely seen in mouse mutants (Tallquist and Soriano,
2003; Beverdam et al., 2001; Lohnes et al., 1994). Similarly,
severe midfacial cleft deformities, which occur either with or
without associated holoprosencephaly, are also rare in humans
(El Hawrani et al., 2006). Because our fate mapping studies
showed that NC cells migrate normally to populate thecraniofacial region in Alk5/Wnt1-Cre mutants, the severe
phenotype appears to be caused, at least in part, by an early
onset of a dramatic increase in mesenchymal apoptosis. This
was detected in the first pharyngeal arch beginning at E10, i.e.,
around the time when the first visible phenotypic alterations
appear. Although apoptotic cells often formed distinctive
groups in multiple locations, it was not possible to match
these patches with the primordia of individual anatomical
structures, or to find any correlation of apoptotic regions with
known expression patterns or pattern overlaps of any genes.
From this stage onwards, the shape of facial prominences in
mutants became morphologically altered to the extent that it was
not possible to obtain sections matching controls. Later, palatal
shelves of Alk5/Wnt1-Cre mutants at E14 demonstrated highly
elevated mesenchymal apoptosis. Although we could not detect
any differences in cell proliferation in the pharyngeal arch
mesenchyme at E10 or E11, the palatal mesenchyme displayed
a significant increase in cell proliferation. In contrast,
corresponding Tgfbr2/Wnt1-Cre mutants displayed decreased
levels of cell proliferation in the palatal mesenchyme (Ito et al.,
2003), suggesting that ALK5 and TGFβRII mediate different
responses in certain NC-derived tissues.
To conclude, the maxillary region is severely affected by the
cell death in the first pharyngeal arch of Alk5/Wnt1-Cremutants
before the palatal shelves are even formed. The initially
insufficient size of the palate is worsened by a persistently
high rate of cell death within the palatal mesenchyme. This
cannot be balanced by an increase in cell proliferation in later
stages, which we think occurs as a compensative effect
secondary to an apoptotic tissue loss.
Signaling via ALK5 differs from the TGFβRII-mediated
signaling in vivo during craniofacial development
The defects in calvaria of the Alk5/Wnt1-Cre mice are
analogous with those found in the corresponding Tgfbr2/Wnt1-
Cre mutants (Ito et al., 2003). In both mutants, defects occurred
not only in bones derived from the neural crest, but also in
mesenchyme-derived structures. Because the role of TGF-β
signaling in morphogenesis of cranial bones has already been
studied in detail in Tgfbr2/Wnt1-Cre mutants (Sasaki et al.,
2006), this study does not address calvarial development.
Interestingly, facial phenotypes of Alk5 mutant mice are far
more severe than those seen in Tgfbr2/Wnt1-Cre embryos. To
explain this phenotypic difference, we considered the possibil-
ity that during facial morphogenesis, ALK5 could become
activated also by the other type II receptors. For example,
GDF11, which is a ligand closely related to TGF-βs, has been
shown in cell culture studies to bind ACVRIIA as well as
ACVRIIB, and to activate Smad2 possibly via ALK5
(Mazerbourg et al., 2004; Oh et al., 2002). Here we show that
Gdf11 is strongly expressed both in maxillary and mandibular
primordia at E10–E11, and in the pre-fusion palatal MEE.
Moreover, we show that its putative binding partner Acvr2B is
strongly expressed in the developing facial prominences. These
findings are in concordance with earlier studies demonstrating
that both Gdf11 and Acvr2B null mutants exhibit cleft palate
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al., 1999; Matzuk et al., 1995).
Consequently, we utilized the regulated heterodimerization
system in a cell culture model to show that, at least in this
simulated set-up, the kinase domain of ACVRIIB can activate
the intracellular domain of ALK5, albeit less efficiently than
that of TGFβRII. Therefore, GDF11 signaling via ACVRIIB
and ALK5 in the neural crest derived facial mesenchyme, may
account for different phenotypes we see in Alk5 mutants, when
compared to corresponding Tgfbr2 mutants. Although not
detected in our experiments, it is possible that ALK5 may also
form signaling complexes with additional type II receptors, and/
or transmit signals mediated by more members of the TGF-β
superfamily ligands than currently known. Thus, widespread
and uniform deletion of Alk5 in the ectomesenchymal cells
would be reflected in a complex phenotype with spatiotempo-
rally complex pattern of localized expression changes of various
genes, which is fully consistent with our findings in Alk5/Wnt1-
Cre mutants.
Changes in gene expression in Alk5/Wnt1-Cre mutants
TGF-β superfamily signaling via Smads is linked to the
etiology of craniofacial malformations with severe midline
defects (Dudas and Kaartinen, 2005; Liu et al., 2004; Nomura
and Li, 1998). Although the Alk5 gene in our Alk5/Wnt1-Cre
mutants has been deleted in a large number of cells, including
the entire craniofacial ectomesenchyme, increased apoptosis
and changes in gene expression occurred in a regionalized and
uneven manner, with no apparent overlap with expression
patterns of genes encoding the TGF-β superfamily members,
receptors, and downstream mediators. Seeing a large number of
various structures affected in Alk5/Wnt1-Cre mutants, encom-
passing all pharyngeal arches, middle ear, frontonasal region,
and skull, it is likely that indeed there is not a single universal
TGF-β downstream gene globally and uniformly affected in all
of these locations. Instead, it is more likely that expression
patterns of multiple different genes are influenced by ALK5
signaling at different time points in small areas all over the head
and neck region.
Our results show significantly reduced expression of the
homeobox gene Msx1 in the maxillary primordia of Alk5/Wnt1-
Cre mutants. TheMsx genes, which are involved in craniofacial
development both in mice (Satokata and Maas, 1994) and
humans (Lidral et al., 1998), are required for NCC survival
(Ishii et al., 2005). Therefore, a dramatic reduction in Msx1
expression could explain increased apoptosis and subsequent
morphological changes localized in the maxillary derivatives.
However, Msx1 expression was not affected in the mandibular
process, indicating that ALK5-mediated signaling initiates
different downstream responses in maxillary and mandibular
primordia.
Expression of Tgif, a gene involved in craniofacial
morphogenesis (Gripp et al., 2000; Wallis and Muenke,
1999), was altered in the upper portion of the maxillary arch,
and in the supranasal region. TGIF is a member of the TALE
superfamily of homeodomain proteins, which can recruitmultiple transcriptional corepressors and repress a diverse set
of genes (Wotton and Massague, 2001; Bertolino et al., 1995),
including interactions with the TGF-β-activated Smads and
repression of TGF-β target genes (Wotton and Massague, 2001;
Wotton et al., 1999). Thus, our current results suggest that TGIF
may represent a novel feedback mechanism to control the level
of Smad activation in the developing face.
Alk5/Wnt1-Cre mutants also displayed subtle changes in the
expression of Fgf8, which is another important player in
craniofacial development (Gong et al., 2005; Albertson and
Yelick, 2005; Mina, 2001; Tucker et al., 1999; Trumpp et al.,
1999), with known interactions with TGF-β/BMP signaling
(Shigetani et al., 2000), including anterior–posterior patterning
of the first pharyngeal arch (Liu et al., 2005; Barlow et al.,
1999). Altogether, our results suggest that TGF-β/ALK5
signaling is a critically important and widespread morphoge-
netic regulator of craniofacial development. In future, multiple
detailed studies focusing on individual anatomical structures
will be required to explain precisely how the ALK5 signaling is
orchestrated with numerous other signaling pathways, and to
elucidate its complex spatiotemporal mode of operation.
Acknowledgments
We thank A. McMahon and S. Millar for providing theWnt1-
Cre and K14-Cre mouse lines, S. Bellusci and A. Joyner for
probes, J. Massague for DR26 cells, and R. Derynck for cDNAs.
MD was supported by the CHLA RCDF Award, YC by grants
from the NIH, and VK by grants from the Robert E. Schneider
Foundation and the NIH (HL074862 and DE013085).References
Akhurst, R.J., Fitzpatrick, D.R., Gatherer, D., Lehnert, S.A., Millan, F.A., 1990.
Transforming growth factor betas in mammalian embryogenesis. Prog.
Growth Factor Res. 2, 153–168.
Albertson, R.C., Yelick, P.C., 2005. Roles for fgf8 signaling in left-right
patterning of the visceral organs and craniofacial skeleton. Dev. Biol. 283,
310–321.
Andl, T., Ahn, K., Kairo, A., Chu, E.Y., Wine-Lee, L., Reddy, S.T., Croft, N.J.,
Cebra-Thomas, J.A., Metzger, D., Chambon, P., Lyons, K.M., Mishina, Y.,
Seykora, J.T., Crenshaw III, E.B., Millar, S.E., 2004. Epithelial Bmpr1a
regulates differentiation and proliferation in postnatal hair follicles and is
essential for tooth development. Development 131, 2257–2268.
Barlow, A.J., Bogardi, J.P., Ladher, R., Francis-West, P.H., 1999. Expression of
chick Barx-1 and its differential regulation by FGF-8 and BMP signaling in
the maxillary primordia. Dev. Dyn. 214, 291–302.
Bei, M., Maas, R., 1998. FGFs and BMP4 induce both Msx1-independent and
Msx1-dependent signaling pathways in early tooth development. Develop-
ment 125, 4325–4333.
Bertolino, E., Reimund, B., Wildt-Perinic, D., Clerc, R.G., 1995. A novel
homeobox protein which recognizes a TGT core and functionally interferes
with a retinoid-responsive motif. J. Biol. Chem. 270, 31178–31188.
Beverdam, A., Brouwer, A., Reijnen, M., Korving, J., Meijlink, F., 2001. Severe
nasal clefting and abnormal embryonic apoptosis in Alx3/Alx4 double
mutant mice. Development 128, 3975–3986.
Brault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D.H., McMahon, A.P.,
Sommer, L., Boussadia, O., Kemler, R., 2001. Inactivation of the beta-
catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain
malformation and failure of craniofacial development. Development 128,
1253–1264.
313M. Dudas et al. / Developmental Biology 296 (2006) 298–314Brewer, S., Feng, W., Huang, J., Sullivan, S., Williams, T., 2004. Wnt1-Cre-
mediated deletion of AP-2alpha causes multiple neural crest-related defects.
Dev. Biol. 267, 135–152.
Carabatsos, M.J., Elvin, J., Matzuk, M.M., Albertini, D.F., 1998. Characteriza-
tion of oocyte and follicle development in growth differentiation factor-9-
deficient mice. Dev. Biol. 204, 373–384.
Couly, G.F., Coltey, P.M., Le Douarin, N.M., 1993. The triple origin of skull in
higher vertebrates: a study in quail-chick chimeras. Development 117,
409–429.
Cuervo, R., Covarrubias, L., 2004. Death is the major fate of medial edge
epithelial cells and the cause of basal lamina degradation during palatogen-
esis. Development 131, 15–24.
Cui, X.M., Shiomi, N., Chen, J., Saito, T., Yamamoto, T., Ito, Y., Bringas, P.,
Chai, Y., Shuler, C.F., 2005. Overexpression of Smad2 in Tgf-beta3-null
mutant mice rescues cleft palate. Dev. Biol. 278, 193–202.
Danielian, P.S., Muccino, D., Rowitch, D.H., Michael, S.K., McMahon, A.P.,
1998. Modification of gene activity in mouse embryos in utero by a
tamoxifen- inducible form of Cre recombinase. Curr. Biol. 8, 1323–1326.
Darling, D.S., Stearman, R.P., Qi, Y., Qiu, M.S., Feller, J.P., 2003. Expression of
Zfhep/deltaEF1 protein in palate, neural progenitors, and differentiated
neurons. Gene Expr. Patterns 3, 709–717.
Derynck, R., Feng, X.H., 1997. TGF-beta receptor signaling. Biochim. Biophys.
Acta 1333, F105–F150.
Dickson, M.C., Slager, H.G., Duffie, E., Mummery, C.L., Akhurst, R.J., 1993.
RNA and protein localisations of TGF beta 2 in the early mouse embryo
suggest an involvement in cardiac development. Development 117,
625–639.
Dudas, M., Kaartinen, V., 2005. Tgf-Beta superfamily and mouse craniofacial
development: interplay of morphogenetic proteins and receptor signaling
controls normal formation of the face. Curr. Top. Dev. Biol. 66, 65–133.
Dudas, M., Nagy, A., Laping, N.J., Moustakas, A., Kaartinen, V., 2004a. Tgf-
beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. Dev. Biol.
266, 96–108.
Dudas, M., Sridurongrit, S., Nagy, A., Okazaki, K., Kaartinen, V., 2004b.
Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural
crest cells. Mech. Dev. 121, 173–182.
El Hawrani, A., Sohn, M., Noga, M., El Hakim, H., 2006. The face does predict
the brain-Midline facial and forebrain defects uncovered during the
investigation of nasal obstruction and rhinorrhea Case report and a review
of holoprosencephaly and its classifications. Int. J. Pediatr. Otorhinolar-
yngol. 70, 935–940.
Ferguson, M.W., 1988. Palate development. Development 103, 41–60 (Suppl.).
Ferguson, C.A., Tucker, A.S., Heikinheimo, K., Nomura, M., Oh, P., Li, E.,
Sharpe, P.T., 2001. The role of effectors of the activin signalling pathway,
activin receptors IIA and IIB, and Smad2, in patterning of tooth
development. Development 128, 4605–4613.
Fitzpatrick, D.R., Denhez, F., Kondaiah, P., Akhurst, R.J., 1990. Differential
expression of TGF beta isoforms in murine palatogenesis. Development
109, 585–595.
Francis-West, P., Ladher, R., Barlow, A., Graveson, A., 1998. Signalling
interactions during facial development. Mech. Dev. 75, 3–28.
Furuta, Y., Piston, D.W., Hogan, B.L., 1997. Bone morphogenetic proteins
(BMPs) as regulators of dorsal forebrain development. Development 124,
2203–2212.
Gong, S.G., Gong, T.W., Shum, L., 2005. Identification of markers of the
midface. J. Dent. Res. 84, 69–72.
Gripp, K.W., Wotton, D., Edwards, M.C., Roessler, E., Ades, L., Meinecke, P.,
Richieri-Costa, A., Zackai, E.H., Massague, J., Muenke, M., Elledge, S.J.,
2000. Mutations in TGIF cause holoprosencephaly and link NODAL
signalling to human neural axis determination. Nat. Genet. 25, 205–208.
Hamrick, M.W., McPherron, A.C., Lovejoy, C.O., 2002. Bone mineral content
and density in the humerus of adult myostatin-deficient mice. Calcif. Tissue
Int. 71, 63–68.
Hanrahan, J.P., Gregan, S.M., Mulsant, P., Mullen, M., Davis, G.H., Powell, R.,
Galloway, S.M., 2004. Mutations in the genes for oocyte-derived growth
factors GDF9 and BMP15 are associated with both increased ovulation rate
and sterility in Cambridge and Belclare sheep (Ovis aries). Biol. Reprod. 70,
900–909.Hilliard, S.A., Yu, L., Gu, S., Zhang, Z., Chen, Y.P., 2005. Regional regulation
of palatal growth and patterning along the anterior–posterior axis in mice.
J. Anat. 207, 655–667.
Hogan, B., Beddington, R., Costantini, F., Lacy, E., 1994. Manipulating the
Mouse Embryo. A Laboratory Manual. Cold Spring Harbor Laboratory
Press, New York.
Ishii, M., Merrill, A.E., Chan, Y.S., Gitelman, I., Rice, D.P., Sucov, H.M.,
Maxson Jr., R.E., 2003. Msx2 and Twist cooperatively control the
development of the neural crest-derived skeletogenic mesenchyme of the
murine skull vault. Development 130, 6131–6142.
Ishii, M., Han, J., Yen, H.Y., Sucov, H.M., Chai, Y., Maxson Jr., R.E., 2005.
Combined deficiencies of Msx1 and Msx2 cause impaired patterning and
survival of the cranial neural crest. Development 132, 4937–4950.
Ito, Y., Yeo, J.Y., Chytil, A., Han, J., Bringas Jr., P., Nakajima, A., Shuler, C.F.,
Moses, H.L., Chai, Y., 2003. Conditional inactivation of Tgfbr2 in cranial
neural crest causes cleft palate and calvaria defects. Development 130,
5269–5280.
Jeong, J., Mao, J., Tenzen, T., Kottmann, A.H., McMahon, A.P., 2004.
Hedgehog signaling in the neural crest cells regulates the patterning and
growth of facial primordia. Genes Dev. 18, 937–951.
Jiang, X., Rowitch, D.H., Soriano, P., McMahon, A.P., Sucov, H.M., 2000. Fate
of the mammalian cardiac neural crest. Development 127, 1607–1616.
Kaartinen, V., Cui, X.M., Heisterkamp, N., Groffen, J., Shuler, C.F., 1997.
Transforming growth factor-beta3 regulates transdifferentiation of medial
edge epithelium during palatal fusion and associated degradation of the
basement membrane. Dev. Dyn. 209, 255–260.
Kaartinen, V., Dudas, M., Nagy, A., Sridurongrit, S., Lu, M.M., Epstein, J.A.,
2004. Cardiac outflow tract defects in mice lacking ALK2 in neural crest
cells. Development 131, 3481–3490.
Kaartinen, V., Voncken, J.W., Shuler, C., Warburton, D., Bu, D., Heisterkamp,
N., Groffen, J., 1995. Abnormal lung development and cleft palate in mice
lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction.
Nat. Genet. 11, 415–421.
Laitinen, M., Vuojolainen, K., Jaatinen, R., Ketola, I., Aaltonen, J., Lehtonen,
E., Heikinheimo, M., Ritvos, O., 1998. A novel growth differentiation
factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse
oocytes during folliculogenesis. Mech. Dev. 78, 135–140.
Larsson, J., Goumans, M.J., Sjostrand, L.J., van Rooijen, M.A., Ward, D.,
Leveen, P., Xu, X., ten Dijke, P., Mummery, C.L., Karlsson, S., 2001.
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type
I receptor-deficient mice. EMBO J. 20, 1663–1673.
Lavrin, I.O., McLean, W., Seegmiller, R.E., Olsen, B.R., Hay, E.D., 2001. The
mechanism of palatal clefting in the Col11a1 mutant mouse. Arch. Oral Biol.
46, 865–869.
Lidral, A.C., Romitti, P.A., Basart, A.M., Doetschman, T., Leysens, N.J., Daack-
Hirsch, S., Semina, E.V., Johnson, L.R., Machida, J., Burds, A., Parnell, T.J.,
Rubenstein, J.L., Murray, J.C., 1998. Association of MSX1 and TGFB3with
nonsyndromic clefting in humans. Am. J. Hum. Genet. 63, 557–568.
Liu, Y., Festing, M., Thompson, J.C., Hester, M., Rankin, S., El Hodiri, H.M.,
Zorn, A.M., Weinstein, M., 2004. Smad2 and Smad3 coordinately regulate
craniofacial and endodermal development. Dev. Biol. 270, 411–426.
Liu, W., Selever, J., Murali, D., Sun, X., Brugger, S.M., Ma, L., Schwartz, R.J.,
Maxson, R., Furuta, Y., Martin, J.F., 2005. Threshold-specific requirements
for Bmp4 in mandibular development. Dev. Biol. 283, 282–293.
Lohnes, D., Mark, M., Mendelsohn, C., Dolle, P., Dierich, A., Gorry, P.,
Gansmuller, A., Chambon, P., 1994. Function of the retinoic acid receptors
(RARs) during development: I. Craniofacial and skeletal abnormalities in
RAR double mutants. Development 120, 2723–2748.
Martin, P., Parkhurst, S.M., 2004. Parallels between tissue repair and embryo
morphogenesis. Development 131, 3021–3034.
Martinez-Alvarez, C., Tudela, C., Perez-Miguelsanz, J., O'Kane, S., Puerta, J.,
Ferguson, M.W., 2000. Medial edge epithelial cell fate during palatal fusion.
Dev. Biol. 220, 343–357.
Martinez-Alvarez, C., Blanco,M.J., Perez, R., Rabadan,M.A., Aparicio,M., Resel,
E., Martinez, T., Nieto, M.A., 2004. Snail family members and cell survival in
physiological and pathological cleft palates. Dev. Biol. 265, 207–218.
Massague, J., Chen, Y.G., 2000. Controlling TGF-beta signaling. Genes Dev.
14, 627–644.
314 M. Dudas et al. / Developmental Biology 296 (2006) 298–314Matzuk, M.M., Kumar, T.R., Bradley, A., 1995. Different phenotypes for mice
deficient in either activins or activin receptor type II. Nature 374, 356–360.
Mazerbourg, S., Klein, C., Roh, J., Kaivo-Oja, N., Mottershead, D.G.,
Korchynskyi, O., Ritvos, O., Hsueh, A.J., 2004. Growth differentiation
factor-9 signaling is mediated by the type I receptor, activin receptor-like
kinase 5. Mol. Endocrinol. 18, 653–665.
McLeod, M.J., 1980. Differential staining of cartilage and bone in whole mouse
fetuses by alcian blue and alizarin red S. Teratology 22, 299–301.
McPherron, A.C., Lee, S.J., 1993. GDF-3 and GDF-9: two new members of the
transforming growth factor-beta superfamily containing a novel pattern of
cysteines. J. Biol. Chem. 268, 3444–3449.
McPherron, A.C., Lee, S.J., 1997. Double muscling in cattle due to mutations in
the myostatin gene. Proc. Natl. Acad. Sci. U. S. A. 94, 12457–12461.
McPherron, A.C., Lee, S.J., 2002. Suppression of body fat accumulation in
myostatin-deficient mice. J. Clin. Invest. 109, 595–601.
McPherron, A.C., Lawler, A.M., Lee, S.J., 1999. Regulation of anterior/
posterior patterning of the axial skeleton by growth/differentiation factor 11.
Nat. Genet. 22, 260–264.
Mina, M., 2001. Morphogenesis of the medial region of the developing
mandible is regulated by multiple signaling pathways. Cells Tissues Organs
169, 295–301.
Moorman, A.F., Houweling, A.C., de Boer, P.A., Christoffels, V.M., 2001.
Sensitive nonradioactive detection of mRNA in tissue sections: novel
application of the whole-mount in situ hybridization protocol. J. Histochem.
Cytochem. 49, 1–8.
Nakashima, M., Toyono, T., Akamine, A., Joyner, A., 1999. Expression of
growth/differentiation factor 11, a new member of the BMP/TGFbeta
superfamily during mouse embryogenesis. Mech. Dev. 80, 185–189.
Nomura, M., Li, E., 1998. Smad2 role in mesoderm formation, left-right
patterning and craniofacial development. Nature 393, 786–790.
Oh, S.P., Yeo, C.Y., Lee, Y., Schrewe, H., Whitman, M., Li, E., 2002. Activin
type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral
patterning. Genes Dev. 16, 2749–2754.
Pelton, R.W., Dickinson, M.E., Moses, H.L., Hogan, B.L., 1990a. In situ
hybridization analysis of TGF beta 3 RNA expression during mouse
development: comparative studies with TGF beta 1 and beta 2. Development
110, 609–620.
Pelton, R.W., Hogan, B.L., Miller, D.A., Moses, H.L., 1990b. Differential
expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine
palate formation. Dev. Biol. 141, 456–460.
Pollock, R., Issner, R., Zoller, K., Natesan, S., Rivera, V.M., Clackson, T., 2000.
Delivery of a stringent dimerizer-regulated gene expression system in a
single retroviral vector. Proc. Natl. Acad. Sci. U. S. A. 97, 13221–13226.
Proetzel, G., Pawlowski, S.A., Wiles, M.V., Yin, M., Boivin, G.P., Howles, P.N.,
Ding, J., Ferguson, M.W., Doetschman, T., 1995. Transforming growth factor-
beta 3 is required for secondary palate fusion. Nat. Genet. 11, 409–414.
Qu, S., Tucker, S.C., Zhao, Q., deCrombrugghe, B., Wisdom, R., 1999. Physical
and genetic interactions between Alx4 and Cart1. Development 126,
359–369.
Rebbapragada, A., Benchabane, H., Wrana, J.L., Celeste, A.J., Attisano, L.,
2003. Myostatin signals through a transforming growth factor beta-like
signaling pathway to block adipogenesis. Mol. Cell. Biol. 23, 7230–7242.
Rice, R., Spencer-Dene, B., Connor, E.C., Gritli-Linde, A., McMahon, A.P.,
Dickson, C., Thesleff, I., Rice, D.P., 2004. Disruption of Fgf10/Fgfr2b-
coordinated epithelial–mesenchymal interactions causes cleft palate. J. Clin.
Invest. 113, 1692–1700.
Rivera, V.M., Clackson, T., Natesan, S., Pollock, R., Amara, J.F., Keenan, T.,
Magari, S.R., Phillips, T., Courage, N.L., Cerasoli Jr., F., Holt, D.A.,
Gilman, M., 1996. A humanized system for pharmacologic control of gene
expression. Nat. Med. 2, 1028–1032.
Saika, S., Saika, S., Liu, C.Y., Azhar, M., Sanford, L.P., Doetschman, T., Gendron,
R.L., Kao, C.W., Kao, W.W., 2001. TGFbeta2 in corneal morphogenesis
during mouse embryonic development. Dev. Biol. 240, 419–432.Sanford, L.P., Ormsby, I., Gittenberger-de Groot, A.C., Sariola, H., Friedman,
R., Boivin, G.P., Cardell, E.L., Doetschman, T., 1997. TGFbeta2 knockout
mice have multiple developmental defects that are non-overlapping with
other TGFbeta knockout phenotypes. Development 124, 2659–2670.
Sasaki, T., Ito, Y., Xu, X., Han, J., Bringas Jr., P., Maeda, T., Slavkin, H.C.,
Grosschedl, R., Chai, Y., 2005. LEF1 is a critical epithelial survival factor
during tooth morphogenesis. Dev. Biol. 278, 130–143.
Sasaki, T., Ito, Y., Bringas Jr., P., Chou, S., Urata, M.M., Slavkin, H., Chai, Y.,
2006. TGF{beta}-mediated FGF signaling is crucial for regulating cranial
neural crest cell proliferation during frontal bone development. Develop-
ment 133, 371–381.
Satokata, I., Maas, R., 1994. Msx1 deficient mice exhibit cleft palate and
abnormalities of craniofacial and tooth development. Nat. Genet. 6,
348–356.
Shigetani, Y., Nobusada, Y., Kuratani, S., 2000. Ectodermally derived FGF8
defines the maxillomandibular region in the early chick embryo: epithelial-
mesenchymal interactions in the specification of the craniofacial ectome-
senchyme. Dev. Biol. 228, 73–85.
Shuler, C.F., 1995. Programmed cell death and cell transformation in
craniofacial development. Crit. Rev. Oral Biol. Med. 6, 202–217.
Soriano, P., 1999. Generalized lacZ expression with the ROSA26 Cre reporter
strain. Nat. Genet. 21, 70–71.
Stockwell, B.R., Schreiber, S.L., 1998. Probing the role of homomeric and
heteromeric receptor interactions in TGF-beta signaling using small
molecule dimerizers. Curr. Biol. 8, 761–770.
Suzuki, A., Ueno, N., Hemmati-Brivanlou, A., 1997. Xenopus msx1 mediates
epidermal induction and neural inhibition by BMP4. Development 124,
3037–3044.
Takigawa, T., Shiota, K., 2004. Terminal differentiation of palatal medial edge
epithelial cells in vitro is not necessarily dependent on palatal shelf contact
and midline epithelial seam formation. Int. J. Dev. Biol. 48, 307–317.
Tallquist, M.D., Soriano, P., 2003. Cell autonomous requirement for
PDGFRalpha in populations of cranial and cardiac neural crest cells.
Development 130, 507–518.
Tanaka, A., Miyamoto, K., Minamino, N., Takeda, M., Sato, B., Matsuo, H.,
Matsumoto, K., 1992. Cloning and characterization of an androgen-induced
growth factor essential for the androgen-dependent growth of mouse
mammary carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 89, 8928–8932.
Taya, Y., O'Kane, S., Ferguson, M.W., 1999. Pathogenesis of cleft palate in
TGF-beta3 knockout mice. Development 126, 3869–3879.
Trumpp, A., Depew, M.J., Rubenstein, J.L., Bishop, J.M., Martin, G.R., 1999.
Cre-mediated gene inactivation demonstrates that FGF8 is required for cell
survival and patterning of the first branchial arch. Genes Dev. 13,
3136–3148.
Tucker, A.S., Al Khamis, A., Sharpe, P.T., 1998. Interactions between Bmp-4
and Msx-1 act to restrict gene expression to odontogenic mesenchyme. Dev.
Dyn. 212, 533–539.
Tucker, A.S., Yamada, G., Grigoriou, M., Pachnis, V., Sharpe, P.T., 1999. Fgf-
8 determines rostral-caudal polarity in the first branchial arch. Development
126, 51–61.
Vaziri, S.F., Hallberg, K., Harfe, B.D., McMahon, A.P., Linde, A., Gritli-Linde,
A., 2005. Fate-mapping of the epithelial seam during palatal fusion rules out
epithelial-mesenchymal transformation. Dev. Biol. 285, 490–495.
Wallis, D.E., Muenke, M., 1999. Molecular mechanisms of holoprosencephaly.
Mol. Genet. Metab. 68, 126–138.
Wotton, D., Massague, J., 2001. Smad transcriptional corepressors in TGF beta
family signaling. Curr. Top. Microbiol. Immunol. 254, 145–164.
Wotton, D., Lo, R.S., Lee, S., Massague, J., 1999. A Smad transcriptional
corepressor. Cell 97, 29–39.
Zhang, Z., Song, Y., Zhao, X., Zhang, X., Fermin, C., Chen, Y., 2002. Rescue of
cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of
BMP and Shh signaling in the regulation of mammalian palatogenesis.
Development 129, 4135–4146.
